Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage

Arthritis and Rheumatism

Volumn 54, Issue 5, 2006, Pages 1653-1661

  Davidson, E N Blaney ^a   Vitters, E L ^a   Mooren, F M ^a   Oliver, N ^b   Van Den Berg, W B ^a   Van Der Kraan, P M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FIBROGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COLLAGENASE 3; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; PROTEIN ADAMTS 4; PROTEIN ADAMTS 5; PROTEOGLYCAN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROSIS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; KNEE; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOPHYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE REPAIR;

ANIMALS; CARTILAGE; FIBROSIS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; SYNOVIAL MEMBRANE;

EID: 33646481194     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21795     Document Type: Article

References (38)

1. Van den Berg WB, van der Kraan PM, Scharstuhl A, van Beuningen HM. Growth factors and cartilage repair. Clin Orthop Relat Res 2001;391:S244-50.
2. Spagnoli A, Longobardi L, O'Rear L. Cartilage disorders: potential therapeutic use of mesenchymal stem cells. Endocr Dev 2005;9:17-30.
3. Fajardo M, di Cesare PE. Disease-modifying therapies for osteoarthritis: current status. Drugs Aging 2005;22:141-61.
4. Zhang H, Liew CC, Marshall KW. Microarray analysis reveals the involvement of β2 microglobulin (B2M) in human osteoarthritis. Osteoarthritis Cartilage 2002;10:950-60.
5. Omoto S, Nishida K, Yamaai Y, Shibahara M, Nishida T, Doi T, et al. Expression and localization of connective tissue growth factor (CTGF/Hcs24/CCN2) in osteoarthritic cartilage. Osteoarthritis Cartilage 2004;12:771-8.
6. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998;30:909-22.
7. Paradis V, Dargere D, Vidaud M, de Gouville AC, Huet S, Martinez V, et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999;30:968-76.
8. Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, Beauchamp JR, et al. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res 2000;259:213-24.
9. Leask A, Sa S, Holmes A, Shiwen X, Black CM, Abraham DJ. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol 2001;54:180-3.
10. Bonniaud P, Margetts PJ, Kolb M, Haberberger T, Kelly M, Robertson J, et al. Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. Am J Respir Crit Care Med 2003;168:770-8.
11. Matsui Y, Sadoshima J. Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy. J Mol Cell Cardiol 2004;37:477-81.
12. Nakata E, Nakanishi T, Kawai A, Asaumi K, Yamaai T, Asano M, et al. Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 (CTGF/Hcs24) during fracture healing. Bone 2002;31:441-7.
13. Yamaai T, Nakanishi T, Asano M, Nawachi K, Yoshimichi G, Ohyama K, et al. Gene expression of connective tissue growth factor (CTGF/CCN2) in calcifying tissues of normal and cbfa1-null mutant mice in late stage of embryonic development. J Bone Miner Metab 2005;23:280-8.
14. Kadota H, Nakanishi T, Asaumi K, Yamaai T, Nakata E, Mitani S, et al. Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 (CTGF/Hcs24/CCN2) during distraction osteogenesis. J Bone Miner Metab 2004;22:293-302.
15. Brigstock DR. The CCN family: a new stimulus package. J Endocrinol 2003;178:169-75.
16. Takigawa M, Nakanishi T, Kubota S, Nishida T. Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell Physiol 2003;194:256-66.
17. Yamaai T, Nakanishi T, Asano M, Nawachi K, Yoshimichi G, Ohyama K, et al. Gene expression of connective tissue growth factor (CTGF/CCN2) in calcifying tissues of normal and cbfa1-null mutant mice in late stage of embryonic development. J Bone Miner Metab 2005;23:280-8.
18. Nishida T, Kubota S, Kojima S, Kuboki T, Nakao K, Kushibiki T, et al. Regeneration of defects in articular cartilage in rat knee joints by CCN2 (connective tissue growth factor). J Bone Miner Res 2004;19:1308-19.
19. Nishida T, Kubota S, Nakanishi T, Kuboki T, Yosimichi G, Kondo S, et al. CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, stimulates proliferation and differentiation, but not hypertrophy of cultured articular chondrocytes. J Cell Physiol 2002;192:55-63.
20. Scharstuhl A, Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 2002;169:507-14.
21. Abreu JG, Ketpura NI, Reversade B, de Robertis EM. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 2002;4:599-604.
22. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, et al. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 2002;16:219-21.
23. McLennan SV, Wang XY, Moreno V, Yue DK, Twigg SM. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy. Endocrinology 2004;145:5646-55.
24. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, et al. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol 2004;31:510-6.
25. Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Does TGFβ protect articular cartilage in vivo? Agents Actions Suppl 1993;39:127-31.
26. Bakker AC, van de Loo FA, van Beuningen HM, Sime P, van Lent PL, van der Kraan PM, et al. Overexpression of active TGFβ-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage 2002;9:128-36.
27. Zhao Q, Chen N, Wang WM, Lu J, Dai BB. Effect of transforming growth factor-β on activity of connective tissue growth factor gene promoter in mouse NIH/3T3 fibroblasts. Acta Pharmacol Sin 2004;25:485-9.
28. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996;7:469-80.
29. Grotendorst GR. Connective tissue growth factor: a mediator of TGFβ action on fibroblasts. Cytokine Growth Factor Rev 1997;8:171-9.
30. Scharstuhl A, Vitters EL, van der Kraan PM, van den Berg WB. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor β/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 2003;48:3442-51.
31. Moussad EE, Brigstock DR. Connective tissue growth factor: what's in a name? Mol Genet Metab 2000;71:276-92.
32. Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, et al. Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model. J Cell Physiol 2005;203:447-56.
33. Minato M, Kubota S, Kawaki H, Nishida T, Miyauchi A, Hanagata H, et al. Module-specific antibodies against human connective tissue growth factor: utility for structural and functional analysis of the factor as related to chondrocytes. J Biochem (Tokyo) 2004;135:347-54.
34. Nakanishi T, Nishida T, Shimo T, Kobayashi K, Kubo T, Tamatani T, et al. Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology 2000;141:264-73.
35. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003;130:2779-91.
36. Luo Q, Kang Q, Si W, Jiang W, Park JK, Peng Y, et al. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004;279:55958-68.
37. Safadi FF, Xu J, Smock SL, Kanaan RA, Selim AH, Odgren PR, et al. Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol 2003;196:51-62.
38. Yamamoto Y, Furukawa K, Ueyama K, Nakanishi T, Takigawa M, Harata S. Possible roles of CTGF/Hcs24 in the initiation and development of ossification of the posterior longitudinal ligament. Spine 2002;27:1852-7.